Fig. 63.1
Diagnostic flow chart in patients with symptoms and clinical signs suggesting a sleep-related obstructive sleep apnea. BMI body mass index, ESS Epworth Sleepiness Scale
Fig. 63.2
The STOP-BANG Questionnaire. A high risk of sleep apnea is defined as a score of 3 or more; low risk of sleep apnea, a score of less than 3
63.3 Intraoperative Management
Although patients with severe OSA seem to be at higher risk of perioperative complications [39], careful observation and early intervention should be recommended for patients with all grades of severity of sleep-disordered breathing [31, 40]. Various strategies can be employed to reduce the risks and avoid adverse outcomes. Preoperatively, the use of anxiolytic premedication is not recommended [41]. There is evidence that regional anesthesia (RA) is preferable over general anesthesia (GA) whenever possible [42]. Regional anesthesia minimally affects respiratory drive, it avoids the side effect of anesthetic agents, particularly on the arousal responses during apneic episodes. Regional anesthesia may also avoid or reduce the need for sedative drugs and opioids during the entire perioperative period. It has been well established that the presence of OSA may lead to difficulties in airway management both in terms of difficult mask ventilation and tracheal intubation [43–46]. Although these findings do not imply that awake intubation is necessary in all patients with OSA, prudence dictates that clinicians should have immediate access to alternative techniques to secure the airway and ventilate the patient. There is evidence that many anesthetic agents cause exaggerated responses in patients with sleep apnea. Drugs such as thiopentone, propofol, opioids, benzodiazepines, and nitrous oxide may blunt the tone of the pharyngeal musculature that acts to maintain airway patency. The choice of induction and maintenance agents is probably not important, although it would seem reasonable to avoid large doses of long-acting drugs. This is true with both neuromuscular blocking agents and benzodiazepines. As a matter of fact, anesthesia techniques using short half-life agents should be advised to avoid any residual drugs in the respiratory system [47, 48]. Whenever the patient is extubated, whether early in the operating room or later in the recovery room or in the ICU, the patient should be fully awake [49]. Full recovery from neuromuscular blockade should be proven by a neuromuscular blockade monitor. In the case of difficult airways, guidelines for safe extubation should be followed [50].
63.4 Postoperative Management
The postoperative disposition of the OSA patient will depend on three main components: invasiveness of the surgery, severity (known or predicted) of OSA, and requirement for postoperative opioids. The American Society of Anesthesiologists (ASA) guidelines suggest that all patients with known or suspected OSA who have received general anesthesia should be monitored in the PACU (post-anesthesia care unit). However, there are currently no evidence-based guidelines addressing the optimal length of monitoring required in the PACU and the ASA recommendations are difficult to adhere to, especially in the context of a community hospital [50].
63.4.1 Role of Noninvasive Ventilation
All patients with OSA or at high risk of having OSA are at possible risk of worsening to acute respiratory failure (ARF). In that case, the patient becomes incapable of maintaining his/her normal value of arterial blood gases due to an acute lung and/or respiratory pump failure. As mentioned above, a potential cause of immediate postoperative hypoxia is upper airway obstruction causing apnea [51]. However, symptoms of OSAs can be exacerbated during the postoperative period as a result of deterioration of the airway condition and rapid eye movement (REM) sleep rebound caused by opioids predisposing to PPCs and adverse outcomes [51, 52]. Patients with OSA after surgery are at high risk of PPCs, not only for adverse effects linked to their underlying disease but also because of pulmonary complications – that is, formation of atelectasis – which increase significantly the risk for pneumonia and ARF [53]. The risk of respiratory events and PPC could be related to the type of surgery [31], with the higher risk being related to upper airway surgery, for the consequent edema of the pharyngeal district [54, 55], and thorax and upper abdomen surgery, for consequent respiratory muscle impairment [56, 57]. Surgery of any type can be burdened by a higher risk of complications in OSA patients [40, 58].
Noninvasive ventilation (NIV), as widely described in the chapters of the present book, refers to the noninvasive delivery via an external interface through the patient’s native airways (mouth, nose, or both) of intermittent positive pressure ventilation (NPPV) or continuous positive airway pressure (CPAP). NIV may improve gas exchange and reduce patient’s effort as invasive mechanical ventilation (IMV) delivered via endotracheal tube or tracheostomy, but differently from IMV, NIV does not interfere with patient native upper airways and, in particular, with glottis function [59–62]. The aims of NIV are to partially compensate for the decreased respiratory function by reducing the work of breathing; to improve alveolar recruitment with better gas exchange (oxygenation and ventilation); and to reduce left ventricular afterload, increasing cardiac output and improving hemodynamics. So it may be an important tool to prevent (prophylactic treatment) or to treat (curative treatment) acute respiratory failure avoiding intubation [53].
CPAP and NPPV have different physiological effects on a patient’s respiratory system and hemodynamics that need some clarifications. Applying noninvasive positive pressure without bypassing the upper airways (oronasal cavities, the pharynx, the larynx including the epiglottis, glottis and subglottis, and upper esophageal sphincter) introduces to the original equation of motion a new variable, namely the pressure needed to overcome upper airway resistances [63]. The glottis, vocal cords, and genioglossus change their activation and function in phase with inspiration and expiration [64, 65]. This explains the results of Parreira et al. [66] demonstrating closure of the glottis at increasing levels of assist pressure, causing a reduction of the effective ventilation. Moreau-Bussière et al. [67] demonstrated that the activation of the thyroarytenoid muscle (a glottal constrictor) at high levels of noninvasive pressure delivery impeded ventilation. As a matter of fact, the equation of motion should be slightly modified from the original equation: P app = Pel + Pres + intrinsic positive end expiratory pressure (PEEPi), where Pel is the pressure needed to overcome the elastic recoil of the lung (P L) and the chest wall (P CW) and Pres is the pressure needed to overcome the lower airways resistances. During NIV, Pres is the pressure needed to overcome both resistances of the lower (P LA) and the upper airways (P UO), so Pres = (P UO + P LA).
63.5 Role of CPAP in the Perioperative Period
Unlike NPPV, during CPAP the pressure applied to the respiratory system is only generated by the patient’s respiratory muscles (P app = P Musc). In this case, transpulmonary pressure, which is generated by the respiratory muscles, has to overcome the upper airway resistances, which means that in patients with OSA CPAP is effective on the lower airways only if it opens the upper airways [68, 69]. CPAP maintains a constant pressure in the upper airways during inspiration and expiration that acts as a pneumatic splint, allowing patency of the upper airway throughout the respiratory cycle [70–72]. Beyond this, CPAP is aimed at improving arterial blood gases and at decreasing work of breathing by:
1.
Increasing functional residual capacity;
2.
Stabilizing the chest wall distortion;
3.
Improving left ventricular performance in chronic heart failure
4.
Offsetting PEEPi (in patients with COPD).
CPAP is aimed at improving oxygenation through an amelioration of ventilation-perfusion mismatch by promoting alveolar recruitment [73] and by maintaining the alveoli open and by counteracting PEEPi alone in association with NPPV [74–76].
Although “genuine” CPAP is commonly used for mild hypoxemic ARF without clear signs of respiratory muscle fatigue, the level of evidence of CPAP effectiveness as a single mode of ventilation support in manifested ARF without cardiopulmonary edema (CPE) is still low [77]. CPAP is also aimed at improving left ventricular performance in chronic heart failure and is considered as a first-line therapy in CPE [78–81. To understand the mechanism of CPAP in patients with OSA it is necessary to focus on the complex mechanisms of heart-lung interaction (Fig. 63.3). With each obstructive event and the associated hypoxemia and hypercapnia, there is a generation of a deep subatmospheric intrathoracic pressure (ITP) due to the occluded airway with associated left ventricular afterload, increased pulmonary artery pressures, decreased left ventricular compliance, and increased myocardial oxygen demand [68]. The heart and lungs share a common intrathoracic compartment. The heart feels as a “container” the modification of ITP generated during changes of transpulmonary pressure during tidal breathing and accordingly modifies both venous return to the heart and left ventricular (LV) ejection pressure [82]. ITP decreases with inspiratory efforts and reducing right atrial pressure will augment venous return and its pressure gradient. In turn, the increase in right ventricular (RV) filling increases RV output, but dilating the right ventricle may theoretically cause the shift of intraventricular septum into the left ventricle, decreasing its diastolic compliance and arterial pulse pressure (pulsus paradoxus) [82]. With sustained decreases in ITP, as may occur with inspiration against an occluded airway (Mueller maneuver), this transient increase in venous return declines with the increased blood flow to the left ventricle and the intraventricular septum returns to its neutral position [83]. However, the decreasing ITP also increases LV afterload because LV ejection occurs into an arterial circuit in which the surrounding pressure is atmospheric pressure, not ITP [82]. LV afterload reflects the maximal wall stress on the left ventricle during ejection. According to the Laplace theorem, LV wall stress is a function of the product of the transmural pressure and the radius of curvature of the left ventricle [82]. This increased afterload explains the development of acute pulmonary edema in patients with severe airways obstruction or with OSA with repetitive negative swings during deep sleep. The increasing wall stress causes subendocardial ischemia and impairs LV systolic performance for a while, even after the strain phase of the increases ITP is over.
Fig. 63.3
Loop of effects on the heart of OSA-related negative intrathoracic pressure. BP blood pressure, IV inter-ventricular, LV left ventricle, OSA obstructive sleep apnea
The oxygen desaturation leads to an increase in pulmonary vascular resistance due to hypoxic pulmonary vasoconstriction. In OSA patients, CPAP improves cardiovascular performance and decreases heart failure by reducing the incidence of both negative swings in ITP and arterial desaturation [84]. Interestingly, patients with chronic heart failure (CHF) have a prolonged depression in LV performance following ITP, even in the absence of hypoxemia [85]. Patients with CHF have increased circulating blood volume. Thus, negative swings in ITP will induce a greater increase in venous return than in healthy volunteers, suggesting that RV dilation is the primary cause of depressed LV performance [82]. Theoretically, measures aimed at reducing circulating blood volume, but also aimed to decrease LV afterload, would limit LV depression during OSA events [82].
Interestingly, Kaw et al. [86], in a study reporting the perioperative outcomes in a large cohort of patients undergoing cardiac surgery, comparing those with and without pulmonary hypertension (PH), found that 27 patients encountered significant postoperative complications. Patient characteristics significantly associated with postoperative mortality and morbidity on univariate analysis were affected by diabetes mellitus (DM), OSA, and chronic renal insufficiency (CRI). CPAP, by reducing the obstructive events, should also reduce the risk of increasing LV afterload.
CPAP is usually provided by a flow generator that delivers constant positive pressure or by ventilators [53, 87–90]. Although the intrathoracic pressure delivered by high-flow CPAP used in intensive care units cannot be compared to the unpredictable levels obtained with the devices commonly used for home treatment of OSA, they are all able to maintain the upper airways open, preventing the occurrence of obstructive events.
When CPAP is delivered by a bi-level turbine-driven ventilator, equal levels of inspiratory positive airway pressure (IPAP) and expiratory positive airway pressure (EPAP)/positive end-expiratory pressure (PEEP) generate CPAP.
63.5.1 Indication for Perioperative CPAP Use
As mentioned above, CPAP remains the most effective therapy for OSA, acting as a pneumatic splint to maintain upper airway patency. It appears that the consistent use of CPAP therapy prior to surgery and immediately after surgery holds the best potential for decreasing postoperative complications. However, CPAP does not provide adequate protection against central apnea, associated with the deterioration of airway condition caused by opioids. Although there are no studies addressing this topic, the use of NPPV with a back-up respiratory rate (i.e., spontaneous timed (ST) mode or assisted pressure controlled ventilation (APCV)) may be advisable [91].
63.5.2 Possible Recommendations
If possible, patients with OSA should be treated with at least 4–6 weeks of CPAP before surgery, because an increase in pharyngeal size and a decrease in tongue volume have been noted on magnetic resonance imaging after 4–6 weeks of nasal CPAP therapy [92, 93].
During induction of anesthesia, CPAP may be indicated to maintain upper airways patency. Eastwood et al. [94] studied 25 patients undergoing minor surgery on their limbs, and they found that patients who needed positive pressure to maintain airway patency had more severe sleep-disordered breathing.
During regional anesthesia, sleep-disordered breathing can occur after even minor surgical procedures on the limbs [94].
After extubation of the surgical patient. Extubation should be performed only when the patient is sufficiently awake, showing an adequate muscle tone in the upper airway, and should be monitored carefully to ensure that the upper airway remains unobstructed. In patients with known OSA, nasal CPAP in the preoperative setting should be started after extubation. Nasal or facial CPAP should be applied if airway obstruction is persistent even after the correct positioning of the patient. The CPAP pressure may need to be adjusted to obtain optimal efficacy. Patients who are unable to sustain spontaneous breathing through an obstructed airway may need NPPV or to undergo reintubation. In one investigation, patients with OSA who received nasal CPAP before surgery and thereafter on an almost continuous basis for 24–48 h for all sleep periods did not experience major complications [95]. Rennotte et al. [95] found that CPAP, started before surgery and resumed immediately after extubation, enabled the safe management of a variety of surgical procedures in patients with OSA, as well as the use of sedative, analgesic, and anesthetic drugs without major complications. Those who conducted the study recommended that every effort should be made to identify patients with OSA and to perform CPAP therapy before surgery. Monitoring may need to be continued in an intermediate care setting for a longer period than that required in patients who do not have OSA. Nursing the patient in the lateral position may be helpful for patients whose airway obstruction is worse in the supine posture. Morbidly obese patients are at elevated risk of perioperative pulmonary complications, including airway obstruction and atelectasis. CPAP may improve postoperative lung mechanics and reduce postoperative complications in patients undergoing abdominal surgery. Neligan et al. [90] found that in 40 morbidly obese patients with OSA undergoing laparoscopic bariatric surgery with standard anesthesia care who were randomly assigned to receive CPAP via the Boussignac system immediately or 30 min after extubation (Boussignac group) or supplemental oxygen (standard care group), the administration of CPAP immediately after extubation maintains spirometric lung function at 24 h after laparoscopic bariatric surgery better than CPAP started in the PACU.Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree